Our vision is to give every person control over their health by providing access to a science-backed, technology-forward platform that decodes the common language of our cells and extends the quality of life for individuals, their families and all of humankind.
Our mission is to extend and improve the quality of life through technology powered by our own cells.
Who We Are
Our team has a diverse set of backgrounds. Some of us are doctors, others are trained research scientists, and still others have experience in pharmaceuticals, healthcare administration, or business. We’re united by a passion for helping people take control of their own health — not just through access to cutting edge treatments, but through knowledge and understanding.
So who are we? We’re experienced doctors. We’re cutting edge researchers. We’re innovative entrepreneurs. Most of all, we’re optimists.
We founded GoodCell on the belief that medical science will continue to progress just as it always has. We think new and emerging research will help us treat diseases in ways we can only dream about now. And nearly every day, we see evidence for this belief. Ongoing trials are showing promise for stem cells to treat cancer, macular degeneration, Parkinson’s, diabetes, heart disease, and many more.
We couldn’t be more excited about the future of medicine, and we can’t wait to share that excitement with you.
Our Scientific Advisors
Simon H. Stertzer Endowed Professor, Stanford School Of Medicine.
Director, Stanford Cardiovascular Institute
Professor Of Stem Cell And Regenerative Biology, Harvard University.
Principal Investigator, Harvard Stem Cell Institute.
Director, Stem Cell Biology, Stanley Center For Psychiatric Research At The Broad Institute.
Dorothy And Milton Flier Professor Of Biomedical Science And Genetics, Harvard Medical School.
Director, Genomic Neurobiology, Stanley Center For Psychiatric Research At The Broad Institute.
Professor Of Medicine, Harvard University.
Professor Of Medicine, Dana-Farber Cancer Institute.
Executive Director, Connell-O’Reilly Cell Manipulation Core Facility At Dana-Farber Cancer Institute.